Shinya Furukawa Selected Research

Shinya Furukawa Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 05/2022 - 01/2012
11	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2012
9	Hypertension (High Blood Pressure) 03/2018 - 01/2016
8	Ulcerative Colitis 04/2022 - 01/2021
7	Insulin Resistance 07/2019 - 01/2007
7	Diabetic Nephropathies (Diabetic Nephropathy) 03/2018 - 01/2014
6	Dyslipidemias (Dyslipidemia) 03/2018 - 01/2016
6	Infections 01/2015 - 01/2004
5	Inflammation (Inflammations) 03/2022 - 03/2013
5	Fatty Liver 10/2021 - 01/2014
5	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2018 - 01/2016
5	Diabetic Neuropathies (Diabetic Neuropathy) 03/2018 - 01/2016
5	Stroke (Strokes) 06/2017 - 01/2016
4	Fibrosis (Cirrhosis) 04/2021 - 01/2012
4	Diabetes Mellitus 07/2019 - 01/2016
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 09/2009
3	Glucose Intolerance 10/2021 - 09/2009
3	Ischemic Stroke 03/2018 - 07/2016
3	Liver Diseases (Liver Disease) 12/2017 - 01/2003
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2016
3	Neoplasms (Cancer) 08/2013 - 06/2007
2	Weight Loss (Weight Reduction) 05/2022 - 09/2018
2	Body Weight (Weight, Body) 05/2022 - 01/2018
2	Hyponatremia 04/2022 - 01/2022
2	Alcoholic Fatty Liver 01/2020 - 07/2019
2	Chronic Renal Insufficiency 02/2019 - 12/2017
2	Obesity 09/2018 - 01/2015
2	Prediabetic State (Prediabetes) 07/2018 - 01/2018
2	Nocturia 03/2018 - 02/2018
2	Hepatitis C 01/2018 - 04/2009
2	Hepatitis B 01/2018 - 07/2007
2	Heart Diseases (Heart Disease) 09/2016 - 07/2016
2	Graves Disease (Basedow Disease) 01/2016 - 01/2013
2	Chronic Hepatitis C 04/2009 - 10/2004
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2005 - 11/2004
2	Chronic Hepatitis B 08/2004 - 07/2004
1	Depressive Disorder (Melancholia) 04/2022
1	Inappropriate ADH Syndrome (SIADH) 04/2022
1	Pain (Aches) 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Wasting Syndrome (Wasting Disease) 01/2022
1	Dysmenorrhea (Menstrual Pain) 01/2022
1	Cholangitis 10/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2018
1	Hearing Loss (Hearing Impairment) 01/2018
1	Asthma (Bronchial Asthma) 01/2018

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2009
8	CreatinineIBA 01/2020 - 01/2014
8	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2018 - 01/2016
6	AlbuminsIBA 03/2022 - 01/2014
6	Insulin (Novolin)FDA Link 07/2019 - 10/2011
5	VaccinesIBA 01/2015 - 01/2004
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2007 - 01/2004
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
4	ORALIT (ORS)IBA 01/2022 - 01/2018
4	Alanine Transaminase (SGPT)IBA 10/2021 - 06/2012
3	HDL CholesterolIBA 01/2020 - 01/2014
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2014
3	Uric Acid (Urate)IBA 01/2018 - 01/2014
3	B-Cell Activating FactorIBA 06/2013 - 10/2011
2	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 05/2022 - 05/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2022 - 01/2018
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2022 - 01/2022
2	Vasopressins (Vasopressin)IBA 04/2022 - 01/2022
2	Tobacco Smoke Pollution (Passive Smoking)IBA 04/2022 - 11/2015
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	InterleukinsIBA 01/2022 - 10/2011
2	BilirubinIBA 02/2021 - 04/2009
2	LipidsIBA 01/2020 - 01/2018
2	Lipoprotein(a)IBA 01/2020 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 06/2017
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2016
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018 - 09/2009
2	Interleukin-18 (Interleukin 18)IBA 11/2017 - 01/2013
2	CytokinesIBA 11/2017 - 01/2015
2	Antiviral Agents (Antivirals)IBA 11/2012 - 06/2004
2	InterferonsIBA 04/2009 - 06/2004
1	semaglutideIBA 05/2022
1	GlobulinsIBA 03/2022
1	Serum GlobulinsIBA 01/2022
1	SaltsIBA 01/2022
1	AntioxidantsIBA 11/2021
1	16S Ribosomal RNAIBA 10/2021
1	EnzymesIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Serum AlbuminIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2020
1	nasIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2019
1	SodiumIBA 09/2018
1	dapagliflozinIBA 09/2018
1	SymportersIBA 09/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2018
1	ipragliflozinIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018

Therapy/Procedure

8	Therapeutics 11/2016 - 01/2003
2	Liver Transplantation 04/2009 - 09/2004
1	Duration of Therapy 04/2022
1	East Asian Traditional Medicine (Oriental Medicine) 01/2018